Chargement en cours...
Palliative chemotherapy with or without anti-EGFR therapy for de novo metastatic nasopharyngeal carcinoma: a propensity score-matching study
OBJECTIVE: We aimed to investigate the efficacy and safety of cetuximab (CTX) or nimotuzumab (NTZ) on the addition of palliative chemotherapy (PCT) in patients with de novo metastatic nasopharyngeal carcinoma (NPC). MATERIALS AND METHODS: From 2007 to 2016, 451 eligible patients with de novo metasta...
Enregistré dans:
| Publié dans: | Drug Des Devel Ther |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6751225/ https://ncbi.nlm.nih.gov/pubmed/31686783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S215190 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|